Epitopea

Epitopea Announces Leadership Transition and New Appointments

Alan C. Rigby Joins as CEO, Jon Moore Transitions to CSO  25 July 2024, Cambridge, UK and Montreal, Canada – Epitopea, a transatlantic RNA immunotherapeutics company and global leader exploiting a new class of untapped tumor-specific antigens, known as CryptigensTM, for the development of off-the-shelf cancer vaccines for difficult to treat cancers announces Dr. Alan...
Salisbury House, Station Road, Cambridge, Cambridgeshire, United Kingdom, CB1 2LA